Immunotherapy has been used in the clinical treatment of colorectal cancer (CRC); however,
most patients fail to achieve satisfactory survival benefits. Biomarkers with high specificity …

Background Soft-tissue sarcoma (STS) represents a rare and diverse cohort of solid tumors,
and encompasses over 100 various histologic and molecular subtypes. In recent years, RNA …

RNA modifications occur through the whole process of gene expression regulation,
including transcription, translation, and post-translational processes. They are closely …

Cancer-associated fibroblasts (CAFs) are actively involved in cancer progression through
generating extracellular matrix and orchestrating the crosstalk within the tumor …

RNA modification has become an exciting underexplored field in recent years. In lung
adenocarcinoma (LUAD), m6A was the best characterized and most studied RNA …

Objective Colorectal cancer (CRC) is a commonly diagnosed human malignancy worldwide.
Both epithelial‐mesenchymal transition (EMT) and N6‐methyladenosine (m6A) modification …

RNA modification, especially N6-methyladenosine, 5-methylcytosine, and N7-
methylguanosine methylation, participates in the occurrence and progression of cancer …

Despite targeted therapies and immunotherapies have revolutionized the treatment of
cancer patients, only a limited number of patients have long-term responses. Moreover, due …

Abstract N6-methyladenosine (m6A) and 5-methylcytosine (m5C) RNA modifications have
garnered significant attention in the field of epigenetic research due to their close …

Long noncoding RNAs (lncRNAs) have been reported to play a key role in regulating tumor
microenvironment and immunity. Cancer-associated fibroblasts (CAFs) are abundant in …